# Immunotherapy Sector

Canonical URL: https://biopharmsignal.com/sector/immunotherapy

Immunotherapy includes companies using the immune system to fight disease, especially cancer and autoimmune conditions. This can include checkpoint inhibitors, immune agonists, engineered immune cells, therapeutic vaccines, and other approaches that modify immune activity.

Companies currently grouped under Immunotherapy: 68

## Recent Sector News

- 2026-09-04 10:00 EST — IMRN — [Immuron to launch PROIBS® in the United States](https://biopharmsignal.com/news/IMRN/immuron-to-launch-proibs-in-the-united-states-e7e76d39) — Source: Immuron
- 2026-09-03 12:05 EST — APVO — [Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML](https://biopharmsignal.com/news/APVO/aptevo-reports-93-clinical-benefit-rate-with-mipletamig-triplet-in-difficult-to--ae677d78) — Source: Aptevo Therapeutics
- 2026-09-03 12:00 EST — REPL — [Replimune to Present at the Cantor Global Healthcare Conference 2026](https://biopharmsignal.com/news/REPL/replimune-to-present-at-the-cantor-global-healthcare-conference-2026-4d1ab8ef) — Source: Replimune Group
- 2026-09-03 11:00 EST — MDNA — [Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference](https://biopharmsignal.com/news/MDNA/medicenna-to-present-at-the-h-c-wainwright-28th-annual-global-investment-confere-9dfcf5cf) — Source: Medicenna Therapeutics Corp.
- 2026-09-03 11:00 EST — RNAC — [Cartesian Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-214697df) — Source: Cartesian Therapeutics
- 2026-09-02 20:30 EST — XLO — [Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/XLO/xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c--2e37223e) — Source: Xilio Therapeutics
- 2026-09-01 20:15 EST — ANAB — [Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference](https://biopharmsignal.com/news/ANAB/anaptys-announces-participation-at-the-h-c-wainwright-28th-annual-global-investm-370d596a) — Source: AnaptysBio, Inc.
- 2026-09-01 20:05 EST — CADL — [Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-7140e4cc) — Source: Candel Therapeutics
- 2026-09-01 11:00 EST — IMCR — [Immunocore to present at upcoming investor conferences](https://biopharmsignal.com/news/IMCR/immunocore-to-present-at-upcoming-investor-conferences-d2bca9c7) — Source: Immunocore Holdings plc
- 2026-08-31 12:00 EST — ELTX — [Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference](https://biopharmsignal.com/news/ELTX/elicio-therapeutics-to-participate-at-the-h-c-wainwright-28th-annual-global-inve-b1f74bbb) — Source: Elicio Therapeutics, Inc.
- 2026-08-29 15:00 EST — BMY — [Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026](https://biopharmsignal.com/news/BMY/bristol-myers-squibb-presents-data-up-to-five-years-reinforcing-the-long-term-ef-186fbc57) — Source: BMYBristol-Myers Squibb Company
- 2026-08-28 10:00 EST — IMRN — [Immuron Reports FY26 Preliminary Results](https://biopharmsignal.com/news/IMRN/immuron-reports-fy26-preliminary-results-3cbe2d6e) — Source: Immuron
- 2026-08-27 20:30 EST — BNTX — [Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine](https://biopharmsignal.com/news/BNTX/pfizer-and-biontech-receive-u-s-fda-approval-for-xfg-adapted-covid-19-vaccine-fd7ed680) — Source: BioNTech
- 2026-08-26 12:30 EST — IMNN — [IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001](https://biopharmsignal.com/news/IMNN/imunon-to-host-2026-r-d-day-highlighting-phase-3-ovation-3-trial-and-the-clinica-e5cc9707) — Source: Imunon
- 2026-08-26 12:05 EST — CADL — [Candel Therapeutics to Present at September Investor Conferences](https://biopharmsignal.com/news/CADL/candel-therapeutics-to-present-at-september-investor-conferences-ea78d0b8) — Source: Candel Therapeutics
- 2026-08-25 11:00 EST — IMTX — [Immatics Announces $150 Million Underwritten Offering](https://biopharmsignal.com/news/IMTX/immatics-announces-150-million-underwritten-offering-0f29dd91) — Source: Immatics
- 2026-08-24 22:57 EST — BRNS — [Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics](https://biopharmsignal.com/news/BRNS/barinthus-bio-provides-update-on-proposed-combination-with-clywedog-therapeutics-73db2c19) — Source: Barinthus Biotherapeutics
- 2026-08-24 12:00 EST — ELTX — [Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference](https://biopharmsignal.com/news/ELTX/elicio-therapeutics-to-participate-at-the-wells-fargo-21st-annual-healthcare-con-70d9d6c7) — Source: Elicio Therapeutics, Inc.
- 2026-08-24 11:30 EST — BCTX — [BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™](https://biopharmsignal.com/news/BCTX/briacell-advances-personalized-melanoma-immunotherapy-vaccine-candidate-bria-mel-f687a234) — Source: BriaCell
- 2026-08-21 12:00 EST — HOWL — [Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement](https://biopharmsignal.com/news/HOWL/werewolf-therapeutics-and-ambros-therapeutics-announce-merger-agreement-and-conc-1c60064c) — Source: Werewolf Therapeutics

## Companies

- [ABBV](https://biopharmsignal.com/company/ABBV) — AbbVie Inc
- [ACIU](https://biopharmsignal.com/company/ACIU) — AC Immune
- [ADAG](https://biopharmsignal.com/company/ADAG) — Adagene
- [ACET](https://biopharmsignal.com/company/ACET) — Adicet Bio
- [ADXS](https://biopharmsignal.com/company/ADXS) — Advaxis
- [AGEN](https://biopharmsignal.com/company/AGEN) — Agenus
- [AMGN](https://biopharmsignal.com/company/AMGN) — Amgen Inc.
- [ANAB](https://biopharmsignal.com/company/ANAB) — AnaptysBio, Inc.
- [APVO](https://biopharmsignal.com/company/APVO) — Aptevo Therapeutics
- [ARGS](https://biopharmsignal.com/company/ARGS) — Argos
- [BCEL](https://biopharmsignal.com/company/BCEL) — Atreca
- [BRNS](https://biopharmsignal.com/company/BRNS) — Barinthus Biotherapeutics
- [BNTX](https://biopharmsignal.com/company/BNTX) — BioNTech
- [BMY](https://biopharmsignal.com/company/BMY) — BMYBristol-Myers Squibb Company
- [BCTX](https://biopharmsignal.com/company/BCTX) — BriaCell
- [CADL](https://biopharmsignal.com/company/CADL) — Candel Therapeutics
- [CARM](https://biopharmsignal.com/company/CARM) — Carisma Therapeutics, Inc.
- [RNAC](https://biopharmsignal.com/company/RNAC) — Cartesian Therapeutics
- [CVM](https://biopharmsignal.com/company/CVM) — Cel-Sci Corporation
- [CDTX](https://biopharmsignal.com/company/CDTX) — Cidara Therapeutics
- [CMPX](https://biopharmsignal.com/company/CMPX) — Compass Therapeutics
- [CGEN](https://biopharmsignal.com/company/CGEN) — Compugen Ltd.
- [CUE](https://biopharmsignal.com/company/CUE) — Cue Biopharma Inc
- [DBVT](https://biopharmsignal.com/company/DBVT) — DBV Technologies
- [ELTX](https://biopharmsignal.com/company/ELTX) — Elicio Therapeutics, Inc.
- [ENLV](https://biopharmsignal.com/company/ENLV) — Enlivex Therapeutics
- [EVAX](https://biopharmsignal.com/company/EVAX) — Evaxion Biotech
- [GNLX](https://biopharmsignal.com/company/GNLX) — Genelux
- [GNTA](https://biopharmsignal.com/company/GNTA) — Genenta Science
- [GOVX](https://biopharmsignal.com/company/GOVX) — GeoVax Labs
- [GRCL](https://biopharmsignal.com/company/GRCL) — Gracell Biotechnologies
- [GLSI](https://biopharmsignal.com/company/GLSI) — Greenwich LifeSciences
- [HNSA](https://biopharmsignal.com/company/HNSA) — Hansa Biopharma AB
- [HOOK](https://biopharmsignal.com/company/HOOK) — HOOKIPA Pharma Inc.
- [IMTX](https://biopharmsignal.com/company/IMTX) — Immatics
- [IBRX](https://biopharmsignal.com/company/IBRX) — ImmunityBio
- [IMCR](https://biopharmsignal.com/company/IMCR) — Immunocore Holdings plc
- [IMRN](https://biopharmsignal.com/company/IMRN) — Immuron
- [IMMP](https://biopharmsignal.com/company/IMMP) — Immutep Limited
- [IMNN](https://biopharmsignal.com/company/IMNN) — Imunon
- [INO](https://biopharmsignal.com/company/INO) — Inovio Pharmaceuticals
- [INTS](https://biopharmsignal.com/company/INTS) — Intensity Therapeutics
- [IOBT](https://biopharmsignal.com/company/IOBT) — IO Biotech
- [ITOS](https://biopharmsignal.com/company/ITOS) — iTeos Therapeutics
- [KA](https://biopharmsignal.com/company/KA) — Kineta
- [LVTX](https://biopharmsignal.com/company/LVTX) — LAVA Therapeutics N.V.
- [LUMO](https://biopharmsignal.com/company/LUMO) — Lumos Pharma
- [LYEL](https://biopharmsignal.com/company/LYEL) — Lyell Immunopharma
- [MDNA](https://biopharmsignal.com/company/MDNA) — Medicenna Therapeutics Corp.
- [MRK](https://biopharmsignal.com/company/MRK) — Merck
- [INKT](https://biopharmsignal.com/company/INKT) — MiNK Therapeutics, Inc.
- [MBIO](https://biopharmsignal.com/company/MBIO) — Mustang Bio
- [NXTC](https://biopharmsignal.com/company/NXTC) — NextCure
- [NWBO](https://biopharmsignal.com/company/NWBO) — Northwest Biotherapeutics
- [ONCR](https://biopharmsignal.com/company/ONCR) — Oncorus
- [PDSB](https://biopharmsignal.com/company/PDSB) — PDS Biotechnology Corporation
- [PHAR](https://biopharmsignal.com/company/PHAR) — Pharming Group
- [PHIO](https://biopharmsignal.com/company/PHIO) — Phio Pharmaceuticals
- [REPL](https://biopharmsignal.com/company/REPL) — Replimune Group
- [SCPS](https://biopharmsignal.com/company/SCPS) — Scopus Biopharma
- [SLS](https://biopharmsignal.com/company/SLS) — SELLAS Life Sciences Group, Inc.
- [SNSE](https://biopharmsignal.com/company/SNSE) — Sensei Biotherapeutics
- [SQZ](https://biopharmsignal.com/company/SQZ) — SQZ Biotech
- [STAB](https://biopharmsignal.com/company/STAB) — Statera Biopharma
- [TPST](https://biopharmsignal.com/company/TPST) — Tempest Therapeutics
- [VAXX](https://biopharmsignal.com/company/VAXX) — Vaxxinity
- [HOWL](https://biopharmsignal.com/company/HOWL) — Werewolf Therapeutics
- [XLO](https://biopharmsignal.com/company/XLO) — Xilio Therapeutics